Study exposes widespread inaccuracies in cannabidiol product labeling
Study reveals significant discrepancies in the labeled and actual cannabidiol content in various commercial products, highlighting a major quality control issue.
Study reveals significant discrepancies in the labeled and actual cannabidiol content in various commercial products, highlighting a major quality control issue.
Biogen plans to retain HI-Bio’s talent, establishing a team in the San Francisco Bay Area to enhance its focus on immune-mediated diseases. Credit: Tada Images
Amgen is enlisting AI startup PostEra for a drug discovery deal for five small molecule programs, PostEra announced Thursday morning. Few details about the collaboration